Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Xylazine Hydrochloride Supplier Information and Product Insights for CAS 2023076-35-9

Nov . 18, 2024 05:45 Back to list

Xylazine Hydrochloride Supplier Information and Product Insights for CAS 2023076-35-9



Understanding Xylazine Hydrochloride CAS 2023076-35-9 and its Implications


Xylazine hydrochloride, identified by its chemical index CAS 2023076-35-9, is a compound that has garnered increasing attention in the pharmaceutical and veterinary fields. Originally developed as a sedative and analgesic agent for veterinary use, its applications have expanded, raising both therapeutic opportunities and concerns regarding misuse.


Chemical Profile and Properties


Xylazine is classified as an alpha-2 adrenergic agonist. This means it works by stimulating certain receptors in the central nervous system, leading to sedation, muscle relaxation, and analgesia. In veterinary medicine, it is predominantly administered to large animals, such as horses and cattle, to facilitate procedures that require sedation. Due to its potent effects, veterinarians utilize xylazine for various purposes including surgeries, diagnostic procedures, and for alleviating anxiety in stressed animals.


The hydrochloride form of xylazine enhances its solubility in water, making it easier to administer through injections. The compound’s pharmacological profile includes a rapid onset of action, typically within minutes, and can last for approximately one to two hours, depending on the dosage and species receiving the treatment.


Manufacturing and Supply Chain


The manufacturing of xylazine hydrochloride involves complex processes, ensuring purity and consistency in its formulation. Various pharmaceutical companies are involved in this production, adhering to stringent quality control measures and regulatory standards to guarantee safety and efficacy. The supply chain for xylazine is critical, particularly in ensuring that the compound is used appropriately and is kept out of the hands of individuals who may use it for non-medical purposes.


cas 23076-35-9 xylazine hydrochloride manufacturer

Xylazine Hydrochloride Supplier Information and Product Insights for CAS 2023076-35-9

Clinical Applications and Off-Label Uses

While xylazine is primarily used in veterinary medicine, there are instances of off-label use within human medicine, especially concerning emergency procedures or in situations where traditional sedatives may not be available. However, the use of xylazine in humans is controversial and necessitates caution, as its side effects can include severe cardiovascular reactions and respiratory depression.


In recent years, xylazine has surfaced in discussions concerning its illicit use in combination with opioids, particularly fentanyl. This poses significant public health challenges, as the substance can exacerbate the sedative effects of opioids, increasing the risk of overdose and complicating treatment protocols.


Regulatory Oversight and Future Directions


As the landscape of drug use evolves, regulatory bodies are tasked with the challenge of overseeing substances like xylazine hydrochloride. Ensuring proper use in veterinary contexts while monitoring its potential for abuse in humans is essential for safeguarding health. Increased awareness around xylazine’s effects, especially in the context of the opioid crisis, is critical for healthcare providers and patients alike.


Educational efforts for veterinarians and the broader medical community are necessary to mitigate risks associated with misuse. Future research is needed to explore alternative analgesics and sedatives, address the challenges posed by mixed drug use, and to develop strategies for responsible prescribing and monitoring.


In conclusion, xylazine hydrochloride (CAS 2023076-35-9) plays a significant role in veterinary medicine, but its implications extend into critical conversations about substance use and public health. Balancing the benefits of this potent sedative with the associated risks will be vital for future applications and regulations.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
haHausa
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu haHausa